$HLF

L'Helias Sophie purchased $14K of HLF

L'Helias Sophie purchased 1,200 shares of HERBALIFE LTD. (HLF) at $11.31 on 2026-06-04.

Original reporting
SEC EDGAR · L'Helias Sophie
Published Jun 4, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HLF
Neutral
medium confidence
Mentioned
$HLF
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HLFNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not introduce new company fundamentals (no guidance, financial results, or deal terms).

02

Market read

Traders may note the buy as a minor bullish sentiment input, but it is unlikely to be a standalone driver of price action.

03

What to watch

Transaction size is small and lacks accompanying narrative; without follow-on buys or operational news, signal-to-noise is low.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today (2026-06-04)

Background

The article is an SEC insider transaction disclosure (Form 4) showing a director’s open-market purchase of HLF shares.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

Director L'Helias Sophie bought 1,200 shares of Herbalife (HLF) in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Limited near-term impact; any effect is likely short-lived unless followed by additional buying or company-specific news.

Evidence & confidence

The filing is an insider transaction (not earnings/guidance/M&A). The disclosed size (~$13.6k) is relatively small, and there is no 10b5-1 plan pre-arrangement noted, but insider buys alone rarely drive sustained repricing.

Market effects

Minimal; this is company-specific insider activity with no stated sector/regulatory trigger.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine diversification or personal liquidity decisions and may not reflect a change in business outlook.

Key entities

  • HERBALIFE LTD.

    Public company whose director disclosed an open-market purchase of shares via SEC Form 4.

  • L'Helias Sophie

    Director who purchased 1,200 shares of HLF at $11.31/share on 2026-06-04.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HLFHigh

Herbalife (HLF) Bets $250M On Its Own Battered Stock

Herbalife (HLF) announced a $250M share buyback program over three years. Q2 sales rose 5.4% YoY to $1.3B, with Latin America and Asia Pacific leading growth. Adjusted EBITDA was $166.6M, near guidance. However, the company reported a net loss of $26.3M due to debt extinguishment costs, and gross margin slipped to 77.7%. Management narrowed full-year adjusted EBITDA guidance to $670M-$690M, citing FX headwinds. CFO John DeSimone will retire at year-end, with Scott Schaefer taking over in 2027. T

$HLFHigh

Herbalife Gains on Stock Buyback

Herbalife (HLF) shares rose 1.4% after the company announced a $250M stock buyback plan over three years, citing confidence in its strategy and financial outlook. The move is part of its capital allocation strategy to return value to shareholders.